Table 3.
Outcome measures
| Variable | Buprenorphine | Methadone | Other opioids | Difference (P value) Buprenorphine vs. methadone | Difference (P value) Buprenorphine vs. other opioids |
|---|---|---|---|---|---|
| Length of Stay (days) | 8.7 (7.3–10.1) | 14.5 (11.9–17.1) | 7.3 (6.1–8.5) | –5.8 (P=0.001*,b) | +1.4 (P=0.315b) |
| Number of Days on Morphine (days) | 4.3 (2.9–5.6) | 10.4 (7.7–13.0) | 3.0 (1.7–4.3) | –6.1 (P<0.001*,b) | +1.3 (P=0.376b) |
| Day of Life of Initiation of Morphine | 2.6 (2.2–3.0) | 1.9 (1.4–2.5) | 2.0 (1.5–2.4) | +0.7 (P=0.122b) | +0.6 (P=0.122b) |
| Adjuvant Medication (Phenobarb) | 4 (6.7%) | 21 (35%) | 3 (5.0%) | –17 (P<0.001*,a) | +1 (NSa) |
Data are n (%) or mean (95% CI) unless otherwise specified, a Pearson chi-square test used, b one-way analysis of variance with Tukey post hoc analyses used, * statistically significant difference P<0.05. NS Bold values are statistically not significant difference or P>0.05.